Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer

Condition:   Breast Cancer Interventions:   Drug: Pyrotinib;   Drug: nab-Paclitaxel;   Drug: Trastuzumab;   Drug: EC chemotherapy;   Procedure: Surgery Sponsors:   Shanghai Jiao Tong University School of Medicine;   Jiangsu HengRui Medicine Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials